Do We Need Models Anymore?

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

Convalescent Plasma: Look Before You Leap
Getting the COVID-19 Numbers Wrong
Giving Models and Modelers a Bad Name
How to Navigate the Blizzard of COVID-19 Antibody Studies